Patrick John Finn

All filings by Patrick John Finn on record concern Twist Bioscience Corp, in the capacity of chief executive. The record holds 105 filings, for trades running from 4 May 2021 to 2 October 2026.

The open-market record consists of 46 sales worth €18.0M, with no purchase. The rest of the record consists of 45 share grants and 14 option exercises. In 2026 alone, the filings show no purchases and 15 sales.

On 5 October 2026 came the latest disclosure, an open-market sale for €4.3M in Twist Bioscience Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.